
INSP · NYSE
Inspire Medical Systems, Inc.
$67.50 -3.08 (-4.33%)
Company overview
Inspire Medical Systems, Inc. is a medical technology company focused on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers the Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It is also developing a novel closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NYSE
- Market cap
- $2B
- Employees
- 1,246
- Headquarters
- Golden Valley, MN
- Website
- inspiresleep.com
- CEO
- Timothy Herbert
- Listed
- May 3, 2018
- P/E
- 14.90
- Dividend yield
- 36.03%
Company financials
- Revenue
- $915M
- Gross profit
- $785M
- Operating income
- $51.3M
- EBITDA
- $72.3M
- Net income
- $131M
- EPS
- $4.53
- Total assets
- $911M
- Total debt
- $29.6M
- Gross margin
- 85.78%
- Net margin
- 14.33%
- Earnings yield
- 6.71%
Showing FY 2025
News